South Danish Obesity Initiative, Screening for Unrecognized Obesity Related Disease
NCT ID: NCT05176132
Last Updated: 2023-10-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
2700 participants
OBSERVATIONAL
2020-09-01
2030-09-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
To evaluate health status participants will be screened by for undetected obesity-related diseases (hypertension, diabetes, dyslipidemia, sleep apnea, non-alcoholic fatty liver disease, chronic obstructive pulmonary disease, EKG-abnormalities, polycystic ovary syndrome (PCOS), and joint pain and for quality of life at baseline, 1 year, and 5 years. Additionally, anthropometric measurements are collected and a biobank is established for future research studies.
People with obesity related disease will be offered participation in a 12 month personalized lifestyle intervention program aimed at improvement of health and self-perception.
The collected data will be used to detect the prevalence for obesity-related disease to identify predictors for future obesity related disease and to evaluate the effect of a lifestyle intervention on health and quality of life.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Feasibility of a Preventive Program Against Lifestyle Related Diseases
NCT02797392
Qingdao Diabetes Prevention Project
NCT01053195
The Cardio-Metabolic Clinic
NCT06203860
An Adjusted Preventive Program Against Lifestyle Related Diseases
NCT03913585
Multicomponent Intervention on Lifestyle, Anthropometric Measurements, Glycemic Control and Quality of Life in Patients Obese People With Type II Diabetes
NCT06222775
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
A Danish cohort of people with BMI \>30 kg/m2 is established on University Hospital South West Jutland. Additionally, one control group with BMI 18.5-25 kg/m2 and one control group with BMI 25-30 kg/m2 will be included. Age range is defined as 18 and 60 years.
To evaluate health status all participants are screened by for undetected obesity-related diseases (hypertension, diabetes, dyslipidemia, sleep apnea, non-alcoholic fatty liver disease, chronic obstructive pulmonary disease, EKG-abnormalities, polycystic ovary syndrome (PCOS) and joint pain.
Data will be collected from questionnaires (Impact of Weight related on Quality of Life, Attitude to physical activity questionnaire, Adult Eating Behavior questionnaire, Berlin sleep apnea and Epworths Sleepiness scale, PCOS related questionnaire including Ferriman-Gallwey score, Work Ability Index, and weight history); clinical laboratory variables (HbA1c, glucose, c-peptide, lipid status, thyroid stimulating hormone (TSH), triiodothyronine (T3), thyroxine (T4), hemoglobin, thrombocytes, alanine aminotransferase (ALAT), aspartate aminotransferase (ASAT), bilirubin, gamma glutamic transferase, lactate dehydrogenase (LDH), alkaline phosphatase, and creatinine levels); and anthropometric measurements (blood pressure, EKG, liver elastography, spirometry (forced expiratory volume during first second as a fraction of forced vital capacity (FEV1/FVC), hand grip strength, gait speed, and CT scan for estimation of the subcutaneous and visceral fat volume). People with diseases uncovered by the screening program will be referred to specialized departments or general practice for further assessment and treatment.
A biobank (blood, feces, urine) is established for future research studies. Patients with obesity related diseases will be invited to participate in a personalized lifestyle intervention program with dietitians and physiotherapists focusing on health improvement through personal motivation, perceived limitations and body accept. Additionally, participants are invited to a 1 year follow-up. All participants, independent of disease status, will be invited for at new screening 5 years after the initial visit.
The data collected for the cohort will be used to estimate the prevalence and development of new obesity-related diseases, and to identify predictors for obesity-related diseases. Finally, the effect of the lifestyle intervention-program will be evaluated.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
OBESE (BMI>30)
BMI above 30 kg/m2 and being 18 to 60 years of age. Since the initiative is open for the general obese population, the investigators did not define the size of the cohort, but expect around 500 referrals per year.
Life style intervention (dietician+ physiotherapist)
Obese patients with obesity related diseases will be invited to participate in a personalized lifestyle intervention program with dieticians and physiotherapists focusing on health improvement through personal motivation and perceived limitations and body accept.
Self management
Patients with no obesity related diseases will not be offered lifestyle intervention, but encouraged to physical activity (self management)
CONTROL Normal weight (BMI 20-25)
100 persons with normal weight (BMI 20 - 25 kg/m2) 18 to 60 years of age
No intervention
Control groups (BMI 20-25 and BMI 25-30)
CONTROL Overweight (BMI 25-30)
100 persons with overweight (BMI 25 - 30 kg/m2) 18 to 60 years of age
No intervention
Control groups (BMI 20-25 and BMI 25-30)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Life style intervention (dietician+ physiotherapist)
Obese patients with obesity related diseases will be invited to participate in a personalized lifestyle intervention program with dieticians and physiotherapists focusing on health improvement through personal motivation and perceived limitations and body accept.
Self management
Patients with no obesity related diseases will not be offered lifestyle intervention, but encouraged to physical activity (self management)
No intervention
Control groups (BMI 20-25 and BMI 25-30)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age 18-60 years
Exclusion Criteria
18 Years
60 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Steno Diabetes Center Odense
OTHER
Odense University Hospital
OTHER
Claus Bogh Juhl
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Claus Bogh Juhl
Professor, MD, PhD
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Claus B Juhl, Prof. PhD MD
Role: PRINCIPAL_INVESTIGATOR
Hospital South West Jutland, University hospital of Southern Denmark
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hospital of South West Jutland, University hospital of Southern Denmark
Esbjerg, , Denmark
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
References
Explore related publications, articles, or registry entries linked to this study.
Juhl CB, Bladbjerg EM, Gram B, Knudsen T, Lauridsen MM, Nygaard NB, Drojdahl Ryg N, Skadhauge L, Munster AB. Prevalence of Obesity-Related Disease in a Danish Population - The Results of an Algorithm-Based Screening Program. Diabetes Metab Syndr Obes. 2024 Jun 19;17:2505-2517. doi: 10.2147/DMSO.S456028. eCollection 2024.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SDOI
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.